Featured Jobs
Retirement Plan Relationship Manager â DB or DC Focus Trinity Pension Consultants
|
Aimpoint Pension
|
Manager - Defined Contribution Plans M2B Retirement Consulting LLC
|
Junior Implementation Specialist - 401(k) Administration Ubiquity Retirement + Savings
|
Jocelyn Pension Consulting
|
Site Manager / Senior Administrator Nicholas Pension Consultants
|
MGKS
|
Senior Defined Contribution Account Manager Nova 401(k) Associates
|
United Benefit Pensions Inc.
|
Retirement, LLC
|
Primark Benefits
|
EPIC RPS
|
Hessel & Associates, LLC
|
Director of Pension Administration Primark Benefits
|
Hicks Pension Services
|
Loren D. Stark Company
|
CMC Pension Professionals
|
401(k) Retirement Plan Administrator Midwest TPA with Remote Workforce |
Loren D. Stark Company
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
 |    |
<< Previous news item | Next news item >>
| Reading Fine Print, Insurers Question Some Drug Studies Wall Street Journal  Aug. 26, 2005 Excerpt: As the cost of drugs in the U.S. approaches $250 billion a year, pharmaceutical companies are running up against a growing breed of detective trained to see through marketing spin. Working for insurers, state Medicaid programs and nonprofit bodies, these detectives cast a wary eye on published studies in medical journals, once considered an unimpeachable source. |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above). |
| An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified). |
